| RiGOR: a prospective observational study comparing the effectiveness of treatment strategies for open-angle glaucoma. |
| Author(s): Coleman AL1,2, Lum FC1, Velentgas P3, Campion D3, Su Z3, Gliklich RE4; RiGOR Study Group. |
| Affiliations(s): 1H. Dunbar Hoskins Jr, MD Center for Quality Eye Care, Foundation of the American Academy of Ophthalmology, 655 Beach Street, San Francisco, CA 94109, USA.
2Jules Stein Eye Institute, David Geffen School of Medicine & Fielding School of Public Health, University of California, Los Angeles, CA 90095, USA.
3Outcome DEcIDE Center, Quintiles Real World & Late Phase Research, Cambridge, MA 02139, USA. |
| Publication(s): Journal of Comparative Effectiveness. Jan 2016; 5(1), 65-78 |
| Document Type(s): Article |
| Countries: |
| Click here for the abstract |
C:
Y: |
Comparative Effectiveness & Health Technology Assessment
2016 |
|
L:
A: |
English
Observational study, Prospective study, RWLPR (Real-World Late Phase Research-quintiles |
|
 |
| |
| |
| Impact of treatment strategies for open angle glaucoma on intraocular pressure: the RiGOR study |
| Author(s): Coleman AL1,2, Lum FC2, Velentgas P3, Su Z3, Gliklich RE4; RiGOR Study Group. |
| Affiliations(s): 1Jules Stein Eye Institute, David Geffen School of Medicine & Fielding School of Public Health, University of California, Los Angeles, CA 90095, USA.
2H Dunbar Hoskins, Jr MD Center for Quality Eye Care, Foundation of the American Academy of Ophthalmology, 655 Beach Street, San Francisco, CA 94109, USA.
3Outcome DEcIDE Center, Quintiles Real World & Late Phase Research, Cambridge, MA 02139, USA.
4Massachusetts Eye & Ear & Harvard Medical School, Boston, MA 02114, USA. |
| Publication(s): J Comp Eff Res. 2016 Jan;5(1):87-98 |
| Document Type(s): Article |
| Countries: |
| Click here for the abstract |
C:
Y: |
Comparative Effectiveness & Health Technology Assessment
2016 |
|
L:
A: |
English
Observational study, Prospective study |
|
|
| |
| |
| Quality of life and visual acuity outcomes in the RiGOR study |
| Author(s): Coleman AL1,2, Lum FC1, Gliklich RE3, Velentgas P4, Su Z4; RiGOR Study Group. |
| Affiliations(s): 1H Dunbar Hoskins, Jr MD Center for Quality Eye Care, Foundation of the American Academy of Ophthalmology, 655 Beach Street, San Francisco, CA 94109, USA.
2Jules Stein Eye Institute, David Geffen School of Medicine & Fielding School of Public Health, University of California, Los Angeles, CA 90095, USA.
3Massachusetts Eye & Ear Infirmary & Harvard Medical School, Boston, MA 02114, USA.
4Outcome DEcIDE Center, Quintiles Real World & Late Phase Research, 201 Broadway #5, Cambridge, MA 02139, USA. |
| Publication(s): J Comp Eff Res. 2016 Jan;5(1):99-111. |
| Document Type(s): Article |
| Countries: |
C:
Y: |
Comparative Effectiveness & Health Technology Assessment
2016 |
|
L:
A: |
English
Observational study, Prospective study |
|
|
| |
| |
| Practice patterns and treatment changes for open-angle glaucoma: the RiGOR study. |
| Author(s): Coleman AL1,2, Lum FC2, Velentgas P3, Su Z3, Gliklich RE4; RiGOR Study Group. |
| Affiliations(s): 1Jules Stein Eye Institute, David Geffen School of Medicine & Fielding School of Public Health, University of California, Los Angeles, CA 90095, USA.
2H Dunbar Hoskins Jr, MD Center for Quality Eye Care, Foundation of the American Academy of Ophthalmology, 655 Beach Street, San Francisco, CA 94109, USA.
3Outcome DEcIDE Center, Quintiles Real World & Late Phase Research, Cambridge, MA, 02139.
4Massachusetts Eye & Ear Infirmary & Harvard Medical School, Boston, MA 02114, USA |
| Publication(s): J Comp Eff Res. 2016 Jan;5(1):79-85. |
| Document Type(s): Article |
| Countries: |
C:
Y: |
Comparative Effectiveness & Health Technology Assessment
2016 |
|
L:
A: |
English
Observational study, Prospective study |
|
|
| |
| |
| How market access will play out
|
| Author(s): Bosco j, Dreyer N |
| Affiliations(s): Quintiles Real World and late phase research |
| Publication(s): Managed healthcare executive |
| Document Type(s): |
| Countries: |
| Click here for the abstract |
C:
Y: |
Comparative Effectiveness & Health Technology Assessment
2016 |
|
L:
A: |
English
RWLPR (Real-World Late Phase Research-quintiles |
|
|
| |
| |
| Comparative Effectiveness of Oxaliplatin Versus 5-flourouricil in Older Adults: An Instrumental Variable Analysis. |
| Author(s): Mack CD1, Brookhart MA, Glynn RJ, Meyer AM, Carpenter WR, Sandler RS, Stürmer T. |
| Affiliations(s): Department of Epidemiology, UNC Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC |
| Publication(s): Epidemiology. 2015 Sep;26(5):690-9. |
| Document Type(s): Article |
| Countries: USA |
C:
Y: |
Comparative Effectiveness & Health Technology Assessment, Oncology
2015 |
|
L:
A: |
English
Retrospective database analysis |
|
|
| |
| |
| Best Methods to Get Your Comparative Effectiveness Paper Cited: How GRACE Helps. |
| Author(s): Dreyer NA, Bryant A, Velentgas P, Su Z. |
| Affiliations(s): Quintales real world and late phase research |
| Publication(s): Pharmacoepidemiol Drug Saf 2015; 24(S1):360 |
| Document Type(s): Abstract |
| Countries: |
C:
Y: |
Comparative Effectiveness & Health Technology Assessment
2015 |
|
L:
A: |
English
Review, RWLPR (Real-World Late Phase Research-quintiles |
|
|
| |
| |
| Generating Real-world Safety and Effectiveness Evidence for Biosimilars: Current Issues and Methodological Considerations |
| Author(s): Bosco JL, Dreyer NA, Neyarapally G, Brown JS. |
| Affiliations(s): Quintiles real world and late phase research |
| Publication(s): Pharmacoepidemiol Drug Saf 2015; 24(S1):416. |
| Document Type(s): Abstract |
| Countries: |
C:
Y: |
Comparative Effectiveness & Health Technology Assessment
2015 |
|
L:
A: |
English
Methodology, Review, RWLPR (Real-World Late Phase Research-quintiles |
|
|
| |
| |
| Comparing Three-way and Pairwise Propensity Score Matching Approaches for Analyses of a Real-world Comparative Effectiveness Study of Glaucoma Therapies (RiGOR). |
| Author(s): Velentgas P, Bosco JLF, Franke KM, Coleman AL, Lum FC, Gliklich R, Park J, Su Z. |
| Affiliations(s): Quintiles real world and late phase research |
| Publication(s): Pharmacoepidemiol Drug Saf 2015; 24(S1):217 |
| Document Type(s): Abstract |
| Countries: |
C:
Y: |
Comparative Effectiveness & Health Technology Assessment
2015 |
|
L:
A: |
English
Methodology, RWLPR (Real-World Late Phase Research-quintiles |
|
|
| |
| |
| Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study. |
| Author(s): Emery P1, Gottenberg JE2, Rubbert-Roth A3, Sarzi-Puttini P4, Choquette D5, Taboada VM6, Barile-Fabris L7, Moots RJ8, Ostor A9, Andrianakos A10, Gemmen E11, Mpofu C12, Chung C13, Gylvin LH12, Finckh A14. |
| Affiliations(s): 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
2Department of Rheumatology, CHU Strasbourg, Strasbourg, France.
3University of Cologne, Cologne, Germany.
4L Sacco University Hospital, Milan, Italy.
5University of Montreal, Montreal, Canada.
6Facultad de Medicina, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain.
7Hospital de Especialidades Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, México City, Mexico.
8Department of Rheumatology, University of Liverpool, Liverpool, UK.
9Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
10Hellenic Foundation for Rheumatological Research, Athens, Greece.
11Quintiles, Rockville, Maryland, USA.
12F Hoffmann-La Roche Ltd, Basel, Switzerland.
13Genentech Inc, San Francisco, California, USA.
14University Hospital of Geneva, Geneva, Switzerland. |
| Publication(s): Ann Rheum Dis. 2015 Jun;74(6):979-84 |
| Document Type(s): Article |
| Countries: Canada, Colombia, France, Germany, Greece, Italy, Mexico, Norway, Portugal, Spain, UK |
| Click here for the abstract |
C:
Y: |
Comparative Effectiveness & Health Technology Assessment, Rheumatology
2015 |
|
L:
A: |
English
Clinical setting: hospital, clinical setting: Secondary care, Prospective study, RWLPR (Real-World Late Phase Research-quintiles |
|
|
| |
| |
 1 of 3 
|
